Winton Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $398K | Sell |
11,049
-21,025
| -66% | -$757K | 0.02% | 641 |
|
|
2025
Q1 | $1.26M | Sell |
32,074
-8,362
| -21% | -$330K | 0.08% | 252 |
|
|
2024
Q4 | $1.22M | Sell |
40,436
-4,645
| -10% | -$140K | 0.08% | 224 |
|
|
2024
Q3 | $1.05M | Buy |
+45,081
| New | +$1.05M | 0.07% | 290 |
|
|
2023
Q2 | – | Sell |
-23,961
| Closed | -$360K | – | 1102 |
|
|
2023
Q1 | $360K | Buy |
23,961
+92
| +0.4% | +$1.38K | 0.02% | 780 |
|
|
2022
Q4 | $282K | Buy |
23,869
+883
| +4% | +$10.4K | 0.02% | 798 |
|
|
2022
Q3 | $136K | Sell |
22,986
-2,729
| -11% | -$16.1K | 0.01% | 890 |
|
|
2022
Q2 | $109K | Buy |
25,715
+5,943
| +30% | +$25.2K | 0.01% | 921 |
|
|
2022
Q1 | $188K | Buy |
19,772
+3,985
| +25% | +$37.9K | 0.01% | 915 |
|
|
2021
Q4 | $300K | Buy |
15,787
+9,108
| +136% | +$173K | 0.02% | 833 |
|
|
2021
Q3 | $222K | Sell |
6,679
-9,517
| -59% | -$316K | 0.01% | 1205 |
|
|
2021
Q2 | $628K | Buy |
16,196
+8,816
| +119% | +$342K | 0.03% | 790 |
|
|
2021
Q1 | $356K | Buy |
+7,380
| New | +$356K | 0.02% | 1063 |
|